全文获取类型
收费全文 | 153458篇 |
免费 | 10090篇 |
国内免费 | 772篇 |
专业分类
耳鼻咽喉 | 1407篇 |
儿科学 | 3902篇 |
妇产科学 | 2765篇 |
基础医学 | 20643篇 |
口腔科学 | 3462篇 |
临床医学 | 14752篇 |
内科学 | 33069篇 |
皮肤病学 | 2876篇 |
神经病学 | 14886篇 |
特种医学 | 6136篇 |
外国民族医学 | 6篇 |
外科学 | 23017篇 |
综合类 | 1907篇 |
现状与发展 | 2篇 |
一般理论 | 140篇 |
预防医学 | 11062篇 |
眼科学 | 3197篇 |
药学 | 10497篇 |
2篇 | |
中国医学 | 245篇 |
肿瘤学 | 10347篇 |
出版年
2023年 | 820篇 |
2022年 | 1241篇 |
2021年 | 2831篇 |
2020年 | 1958篇 |
2019年 | 2820篇 |
2018年 | 3441篇 |
2017年 | 2673篇 |
2016年 | 3050篇 |
2015年 | 3522篇 |
2014年 | 5039篇 |
2013年 | 6824篇 |
2012年 | 10536篇 |
2011年 | 11154篇 |
2010年 | 6355篇 |
2009年 | 6048篇 |
2008年 | 10209篇 |
2007年 | 10893篇 |
2006年 | 10372篇 |
2005年 | 10610篇 |
2004年 | 10022篇 |
2003年 | 9498篇 |
2002年 | 8919篇 |
2001年 | 1503篇 |
2000年 | 1122篇 |
1999年 | 1599篇 |
1998年 | 2109篇 |
1997年 | 1646篇 |
1996年 | 1426篇 |
1995年 | 1289篇 |
1994年 | 1143篇 |
1993年 | 1115篇 |
1992年 | 786篇 |
1991年 | 789篇 |
1990年 | 615篇 |
1989年 | 601篇 |
1988年 | 560篇 |
1987年 | 571篇 |
1986年 | 515篇 |
1985年 | 536篇 |
1984年 | 638篇 |
1983年 | 568篇 |
1982年 | 762篇 |
1981年 | 702篇 |
1980年 | 605篇 |
1979年 | 366篇 |
1978年 | 378篇 |
1977年 | 406篇 |
1976年 | 345篇 |
1975年 | 294篇 |
1974年 | 251篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Peter J. Morgan Lynda M. Williams Gary Davidson Wilfred Lawson Edward Howell 《Journal of neuroendocrinology》1989,1(1):1-4
The functional significance of the pars tuberalis (PT) of the mammalian adenohypophysis has remained an enigma (1, 2). One view of its function is that it acts as an auxiliary gland to support the endocrine role of the pars distalis (PD) (2), as it has been shown to contain immunocytochemically identifiable thyrotrophs and gonadotrophs (1). Many of the cells of the PT are, however, ultrastructurally unique suggesting an independent function for this tissue. Our recent demonstration that the PT of the rat is a major binding site for the ligand iodomelatonin lends further support to this idea (3). We have utilized the highly specific ligand [125 l]melatonin, and have demonstrated that it binds exclusively, with very high affinity, to the PT but not the PD of the adult sheep adenohypophysis. These findings support the conclusion that the PT has a distinct role in relation to melatonin action and seasonal reproduction. 相似文献
52.
TB in the elderly in industrialised countries. 总被引:1,自引:0,他引:1
Peter D O Davies 《The international journal of tuberculosis and lung disease》2007,11(11):1157-1159
53.
54.
Alemtuzumab (CAMPATH 1H) Induction Therapy in Cadaveric Kidney Transplantation—Efficacy and Safety at Five Years 总被引:2,自引:0,他引:2
Christopher J. E. Watson J. Andrew Bradley Peter J. Friend John Firth Craig J. Taylor John R. Bradley Kenneth G. C. Smith Sathia Thiru Neville V. Jamieson Geoff Hale Herman Waldmann Roy Calne 《American journal of transplantation》2005,5(6):1347-1353
Alemtuzumab is a powerful lymphocyte depleting antibody currently being evaluated in solid organ transplantation. This paper describes 5-year results of a single center study of alemtuzumab as induction in renal transplantation. Thirty-three renal transplant recipients received 20 mg alemtuzumab on day 0 and 1, followed by half-dose cyclosporin monotherapy (trough concentration 75-125 ng/mL) from day 3. They were compared in a retrospective contemporaneous-controlled manner with 66 kidney transplant recipients transplanted in the same period and center who received conventional immunosuppression with cyclosporin, azathioprine and prednisolone. In the alemtuzumab group 12% of recipients died compared to 17% in the control group (p = 0.48); likewise graft loss was similar in both groups (21% vs. 26%, respectively, p = 0.58). Incidence of acute rejection was also comparable at 5 years (31.5% vs. 33.6%), although the pattern of rejection was different with 14% patients in the alemtuzumab group experiencing rejection over 1 year post-transplant compared to none in the control group. There was no significant difference between groups in terms of infection or serious adverse events. While acknowledging the limitations of a relatively small single-center study, results suggest that alemtuzumab induction allowed satisfactory long-term patient and graft survival equivalent to that seen with standard triple immunosuppression, while avoiding steroid therapy. 相似文献
55.
56.
57.
Najat C Daw Wayne L Furman Clinton F Stewart Lisa C Iacono Mark Krailo Mark L Bernstein Janet E Dancey Rose Anne Speights Susan M Blaney James M Croop Gregory H Reaman Peter C Adamson 《Journal of clinical oncology》2005,23(25):6172-6180
PURPOSE: Epidermal growth factor receptor is expressed in pediatric malignant solid tumors. We conducted a phase I trial of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in children with refractory solid tumors. PATIENTS AND METHODS: Gefitinib (150, 300, 400, or 500 mg/m2) was administered orally to cohorts of three to six patients once daily continuously until disease progression or significant toxicity. Pharmacokinetic studies were performed during course one (day 1 through 28). RESULTS: Of the 25 enrolled patients, 19 (median age, 15 years) were fully evaluable for toxicity and received 54 courses. Dose-limiting toxicity was rash in two patients treated with 500 mg/m2 and elevated ALT and AST in one patient treated with 400 mg/m2. The maximum-tolerated dose was 400 mg/m2/d. The most frequent non-dose-limiting toxicities were grade 1 or 2 dry skin, anemia, diarrhea, nausea, and vomiting. One patient with Ewing's sarcoma had a partial response. Disease stabilized for 8 to > or = 60 weeks in two patients with Wilms' tumor and two with brainstem glioma (one exophytic). At 400 mg/m2, the median peak gefitinib plasma concentration was 2.2 microg/mL (range, 1.2 to 3.6 microg/mL) and occurred at a median of 2.3 hours (range, 2.0 to 8.3 hours) after drug administration. The median apparent clearance and median half-life were 14.8 L/h/m2 (range, 3.8 to 24.8 L/h/m2) and 11.7 hours (range, 5.6 to 22.8 hours), respectively. Gefitinib systemic exposures were comparable with those associated with antitumor activity in adults. CONCLUSION: Oral gefitinib is well tolerated in children. Development of the drug in combination with cytotoxic chemotherapy will be pursued. 相似文献
58.
Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. 总被引:4,自引:0,他引:4
Thomas J Spencer Joseph Biederman Bertha K Madras Darin D Dougherty Ali A Bonab Elijahu Livni Peter C Meltzer Jessica Martin Scott Rauch Alan J Fischman 《Neuropsychopharmacology》2007,62(9):1059-1061
BACKGROUND: The dopamine transporter (DAT) is known to be a key regulator of dopamine, and recent studies of genetics, treatment, and imaging have highlighted the role of DAT in attention-deficit/hyperactivity disorder (ADHD). The findings of in vivo neuroimaging of DAT in ADHD have been somewhat discrepant, however. METHOD: Dopamine transporter binding was measured using a highly selective ligand (C-11 altropane) and positron emission tomography (PET). The sample consisted of 47 well-characterized, treatment-na?ve, nonsmoking, non-comorbid adults with and without ADHD. Additionally, control subjects had few symptoms of ADHD. RESULTS: Results showed significantly increased DAT binding in the right caudate in adults with ADHD compared with matched control subjects without this disorder. CONCLUSIONS: These results confirm abnormal DAT binding in the striatum of adults with ADHD and provide further support that dysregulation of DAT may be an important component of the pathophysiology of ADHD. 相似文献
59.
Charlotte J. Harden Bernard M. Corfe J. Craig Richardson Peter W. Dettmar Jenny R. Paxman 《Nutrition Research》2009
This cross-sectional analysis evaluated the effect of age and body mass index (BMI) on Three-Factor Eating Questionnaire scores in males. Subjects (n = 60) were recruited according to BMI status. Each completed the 51-item Three-Factor Eating Questionnaire. The group was split at the median age to produce a “younger” and “older” group for statistical analysis. A 2-way between-groups analysis of variance revealed a significant main effect of BMI on disinhibition (P = .003) and hunger (P = .041) with higher levels found in overweight males compared to healthy-weight counterparts. A significant main effect of age on hunger (P = .046) demonstrated older males were less susceptible to hunger than younger males. These insights provide a better understanding of eating behavior across the male life cycle and may assist health professionals to better guide men in weight management in the light of rising overweight/obesity. 相似文献
60.